SBIR/STTR Research Award

Gold Nanoparticle Treatment of Glioma

Award identifier 9dc6b08e56e6ad3d3b382a506fd856b3c3a16f16c50653a1a2c78b54445b6b3aAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$245,977

Program and phase

SBIR · Phase I

Award year

2016

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
NANOPROBES INC
Proposal award date
2016-05-01
Contract end date
2018-04-30
UEI
JK7BK6JL14M6
Solicitation number
PA15-269
Topic code
102

Research abstract

DESCRIPTION provided by applicant Every year more than people in the U S are diagnosed with primary brain tumors with deaths The five year survival rate is Primary brain tumors also account for of the cancers in children More effective treatments of malignant brain tumors are desperately needed We have pioneered the use of gold nanoparticles AuNPs to enhance radiotherapy In previous work we showed that Nanogold enhanced radiosurgery of a very aggressive orthotopic glioma in mice resulted in long term survival andgt days compared to with radiosurgery alone The AuNPs were IV administered Concerns about translation to humans of this very promising result include a the high cost of gold actually less than many antibody therapies b slow body clearance and c effectiveness of the Enhanced Permeability andamp Retention EPR effect for delivery in humans Upon further analysis we now propose a novel procedure to overcome not just these objections but the true barriers to effective glioma therapy After urgent surgery to remove the primary brain tumor and relieve dangerous intracranial pressure recurrence invariably develops Surgery typically does not remove the entire tumor especially difficult since tumor cells migrate even up to cm A number of studies have shown escaping tumor cells migrate in the peritumor edema often along white matter tracts Our hypothesis is that AuNPs can be designed to also move and distribute in this peritumor edema When infused in the primary tumor site they will because of their smaller size andquot catch upandquot to and engulf migrating tumor cells A gold concentration will be administered that will lead to enhancing radiotherapy by a factor of boosting Gy to Gy Normal brain would be spared since the X ray generated electrons from the gold only travel several microns thus tightly confining the boosted radiation dose To test this F tumor cells will be transduced with red fluorescent protein and luciferase and tumors orthotopically grown in rats The small AuNPs will be visualized with silver enhancement and the coincidence of AuNPs and tumor cells will be studied histologically Edema will be stained with anti albumin FITC Acceptable toxicity will be sought Radiotherapy will test efficacy Another advantage of this approach is that radiation resistant cancer stem cell as well as dormant and drug resistant tumor cells will be killed since the target of the increased radiation is the tumor cellsandapos DNA itself rather than any particular metabolic pathway This approach overcomes concerns of cost of an IV injection of gold a much smaller amount needed locally Loading other organs and whole body retention will be minimal and the gold no longer has to pass through a leaky endothelium it is administered directly to the edema in which the tumor cells reside Importantly it addresses the main reason why all current GBM therapies fail ineffective treatment of residual and migrant cells This approach represents a major paradigm shift for radiotherapy since a larger brain volume to cover the escaped cells will be irradiated a procedure now forbidden due to whole brain radiation constraints but now made possible via the very specific gold boost PUBLIC HEALTH RELEVANCE A new method is proposed using gold nanoparticles to kill brain tumor cells that currently evade surgery radiotherapy and chemotherapy This could significantly improve outcomes from one of the most dangerous and difficult to treat cancers

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

47 SBIR/STTR records share this UEI (1991–2025). Reported award amounts total $12,102,185. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, National Science Foundation, Department of Energy

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.